Biotechnology Developer | |
Founded | 2004 |
Headquarters | Jersey, Channel Islands UK |
Parent | Clasado BioSciences Ltd |
Website | http://www.bimuno.com/ |
Bimuno is a bio-engineered second generation Prebiotic (nutrition) food supplement. The prebiotic supplement was developed by Clasado BioSciences, an international Biotechnology company based in Jersey, UK.
The concept of prebiotics was first described by Glenn Gibson, (then at the Institute of Food Research, Reading) and Marcel Roberfroid (at the University Catholique Louvain, Belgium) in 1995. As Professor of Food Microbiology at the University of Reading in 1999, Gibson has continued his work on prebiotics, including the development of Bimuno - a prebiotic for use in humans. The Bimuno development programme combined Gibson’s research on prebiotics with Professor Bob Rastall’s (Department of Food and Nutritional Sciences, 1994 – present) research on enzymic development of functional food ingredients.
Bimuno is a Dietary supplement containing Galactooligosaccharides (β-Galacto-Oligosaccharide).
β-Galacto-Oligosaccharide (Bimuno®) is one of a group of nutrient fibres (Oligosaccharides). Oligosaccarides feed and cultivate certain types of friendly Bacteria found in the gut.
Bimuno Powder Ingredients
Bimuno's formulation, technology, production and brand positioning are all recognised and protected by worldwide patents and trademarks.
According to the manufacturer's website, Bimuno is the result of research and development including Peer reviews and Clinical trials conducted in collaboration with the University of Reading’s Food Microbial Sciences Unit and other global research institutes.
Clasado BioSciences is an International Biotechnology company headquartered on the island of Jersey in The Channel Islands.
Clasado BioSciences researches and develops galacto-oligosaccharide (GOS) products for Food, Healthcare and Pharmaceutical companies.
Clasado BioSciences are developers and manufacturers of prebiotic technologies.